New York State Common Retirement Fund
ABUS icon

New York State Common Retirement Fund’s Arbutus Biopharma ABUS Stock Holding History

New York State Common Retirement Fund’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$169K Hold
35,268
– – ﹤0.01% 2438
2026
Q1 		$159K Hold
35,268
– – ﹤0.01% 2324
2025
Q4 		$170K Hold
35,268
– – ﹤0.01% 2361
2025
Q3 		$160K Buy
35,268
+13,400
+61% +$49.2K ﹤0.01% 2393
2025
Q2 		$67.6K Hold
21,868
– – ﹤0.01% 2856
2025
Q1 		$76.3K Hold
21,868
– – ﹤0.01% 2634
2024
Q4 		$71.5K Hold
21,868
– – ﹤0.01% 2733
2024
Q3 		$84.2K Sell
21,868
-23,100
-51% -$88.6K ﹤0.01% 2670
2024
Q2 		$139K Buy
44,968
+620
+1% +$1.86K ﹤0.01% 2589
2024
Q1 		$114K Sell
44,348
-658
-1% -$1.7K ﹤0.01% 2685
2023
Q4 		$113K Sell
45,006
-240
-0.5% -$470 ﹤0.01% 2704
2023
Q3 		$91.8K Buy
45,246
+473
+1% +$992 ﹤0.01% 2772
2023
Q2 		$103K Sell
44,773
-120
-0.3% -$312 ﹤0.01% 2800
2023
Q1 		$136K Sell
44,893
-30,513
-40% -$86.1K ﹤0.01% 2730
2022
Q4 		$176K Sell
75,406
-70
-0.1% -$167 ﹤0.01% 2780
2022
Q3 		$144K Buy
75,476
+344
+0.5% +$810 ﹤0.01% 2892
2022
Q2 		$204K Buy
75,132
+41,915
+126% +$107K ﹤0.01% 2795
2022
Q1 		$99K Buy
33,217
+41
+0.1% +$126 ﹤0.01% 3018
2021
Q4 		$129K Sell
33,176
-146
-0.4% -$567 ﹤0.01% 3012
2021
Q3 		$143K Sell
33,322
-33,578
-50% -$112K ﹤0.01% 3024
2021
Q2 		$203K Buy
+66,900
New +$207K ﹤0.01% 3035
2019
Q2 		– Sell
-24,500
Closed -$88K – 3236
2019
Q1 		$88K Hold
24,500
– – ﹤0.01% 2986
2018
Q4 		$94K Hold
24,500
– – ﹤0.01% 2977
2018
Q3 		$232K Hold
24,500
– – ﹤0.01% 2766
2018
Q2 		$179K Buy
+24,500
New +$146K ﹤0.01% 2917
2014
Q2 		– Sell
-135,650
Closed -$2.92M – 2000
2014
Q1 		$2.92M Buy
+135,650
New +$2.44M ﹤0.01% 1471

Other funds holding ABUS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
FCH
Freestone Capital Holdings Seattle, Washington $3.86B AUM 26.3% 1-Year Est. Return
LWA
Ledgewood Wealth Advisors Exeter, New Hampshire $188M AUM 18.45% 1-Year Est. Return
CCA
Carrera Capital Advisors Troy, Michigan $675M AUM 17.92% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

New York State Common Retirement Fund's ABUS Position: Q2 2026 in Review

New York State Common Retirement Fund held its Arbutus Biopharma (ABUS) position steady in Q2 2026 at 35,268 shares worth $169K. The position accounts for ﹤0.01% of the portfolio, ranked #2438.

New York State Common Retirement Fund first reported a position in ABUS in Q1 2014 and has held it in 26 quarters since. The position peaked at $2.92M in Q1 2014. 51 funds tracked by Wall St. Rank hold ABUS as of Q2 2026.

  • New York State Common Retirement Fund held 35,268 shares of Arbutus Biopharma worth $169K as of Q2 2026.
  • New York State Common Retirement Fund left its Arbutus Biopharma share count unchanged in Q2 2026.
  • Arbutus Biopharma made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2438 holding.
  • New York State Common Retirement Fund first reported a position in Arbutus Biopharma in Q1 2014 and has held it in 26 quarters since.
  • New York State Common Retirement Fund's Arbutus Biopharma position peaked at $2.92M in Q1 2014.
  • 51 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.